Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of UQCRB mRNA | affects expression | 21346803
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of UQCRB mRNA | decreases expression | 12958071
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of UQCRB mRNA] | decreases reaction|increases expression | 16964424
|
D019259 |
Lamivudine |
[Zidovudine co-treated with Lamivudine] results in increased expression of UQCRB mRNA | affects cotreatment|increases expression | 18313992
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of UQCRB protein | increases expression | 16144979
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of UQCRB mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of UQCRB mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UQCRB mRNA | affects cotreatment|increases expression | 17942748
|
D005472 |
Fluorouracil |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of UQCRB mRNA] | affects reaction|decreases expression | 15016801
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of UQCRB mRNA | affects cotreatment|increases expression | 17183730
|
D008628 |
Mercury |
Mercury results in increased expression of UQCRB mRNA | increases expression | 16823088
|
D015735 |
Mifepristone |
Mifepristone results in increased expression of UQCRB mRNA | increases expression | 17584828
|
D012402 |
Rotenone |
Rotenone results in increased expression of UQCRB mRNA | increases expression | 18191903
|
D012643 |
Selenium |
Selenium results in decreased expression of UQCRB mRNA | decreases expression | 19244175
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of UQCRB mRNA | increases expression | 18175754
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of UQCRB mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UQCRB mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of UQCRB mRNA | decreases expression | 20399798
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of UQCRB mRNA | affects cotreatment|increases expression | 17183730
|
D015215 |
Zidovudine |
[Zidovudine co-treated with Lamivudine] results in increased expression of UQCRB mRNA | affects cotreatment|increases expression | 18313992
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.55 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.28 | 11752688 15322242 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.28 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.91 | 19490988 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.94 | 17505938 |
MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
4.81 | 9612607 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
7.10 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
7.10 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
7.10 | 17638652 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.37 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.53 | 21441931 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.23 | 17688650 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.62 | 16511603 17963324 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.62 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.55 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.45 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.65 | 15885639 |
MESH:D001321 |
Autistic Disorder |
|
Mercury |
2.35 | 17497416 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.35 | 18177632 17688650 19460635 17157402 15238991 18940202 18396377 18775368 19232924 17507914 18316065 16609825 18985861 20603192 18558336 |
MESH:D001327 |
Autoimmune Diseases |
|
Mercury |
4.86 | 16634805 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.06 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.02 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.79 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.98 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.98 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.70 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.79 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
1.96 | 15939500 15567936 18382427 19526202 18695136 17983394 16264153 16322301 15136595 11325840 16935488 15668708 15994142 18628466 16595493 17426702 15634643 18234424 15993339 16826403 17369602 16096432 16115903 15692762 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
1.96 | 19217205 16110121 15136595 16595493 18608205 18357371 16557594 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.96 | 19155303 15668708 17242785 17261762 11161223 19011961 19103187 17893378 18984771 20859285 19244106 18815881 20065188 16873071 18351453 20544844 18821012 18855134 20005174 19221464 18425577 18629630 19066611 21138602 20135344 19115204 18997820 15565566 16818667 16202921 16273361 21152245 19059307 17049068 19142967 19487384 19288272 19084267 19200415 19410462 19289846 19189212 20390343 17440819 19189210 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.96 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
12.35 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
12.35 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.13 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.13 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.49 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.58 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
6.58 | 16234567 18059187 17876044 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
6.58 | 17971768 17088986 16332177 18930000 17045692 16799960 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
6.58 | 16924424 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.64 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
6.64 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.84 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
4.84 | 18986760 17066447 16280240 16757204 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.60 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.35 | 18850075 16120746 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.51 | 17924179 16364871 18627295 16612575 15811867 17519947 16731534 17131338 17351982 16242529 17928571 16455267 17382496 17007740 15505089 16109756 15792986 17329180 15476868 17974986 16952015 16278810 17308081 16269455 16651473 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
6.16 | 16243910 17334414 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Mercury |
6.16 | 10334427 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.75 | 6135515 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.70 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.14 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.86 | 17110522 16105132 15861022 17681005 17333356 16919318 11677210 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.74 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.09 | 15340226 15668235 8697196 12621046 16354765 |
MESH:D003092 |
Colitis |
|
Selenium |
3.77 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.23 | 17725105 17287894 18772588 17018589 17172411 15001691 16510598 16340194 17169374 17016597 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.64 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.64 | 17454858 18383874 16303861 17594712 17401013 15289873 14970324 17695437 16331619 17094418 15148649 16282729 18509181 18949393 18802399 17016601 18448328 16391804 20501625 18288408 16524972 17255274 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.04 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.47 | 20055451 15322242 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.47 | 8888407 17688650 16575769 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.00 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.78 | 16733453 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.35 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Mercury |
3.78 | 16823706 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.76 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
astaxanthine |
4.86 | 16964424 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.86 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.46 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
15.20 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
15.20 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
15.20 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
15.20 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
15.20 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
15.20 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
19.54 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Lamivudine |
19.54 | 15040536 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
19.54 | 11462148 |
MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
19.54 | 15040536 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.03 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.36 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.90 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.89 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.89 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.52 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.52 | 20544844 19155303 17893378 16202921 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
9.09 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.09 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.16 | 18037988 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.14 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.92 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.92 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.57 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.28 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.06 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
2.44 | 16481741 16337965 15173087 16785472 17638652 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
18.67 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
18.67 | 19224547 14986274 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
18.67 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Zidovudine |
18.67 | 18299183 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.22 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.44 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.89 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.11 | 18558336 8888407 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.52 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
11.41 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
11.41 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.93 | 20067830 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.33 | 17150277 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.86 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.59 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.87 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
7.87 | 18337622 15102660 15162350 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.32 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.47 | 16144979 17875725 17888722 16244372 16330681 16879835 14766674 16495754 16244371 18006777 18674790 12587719 16707910 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.20 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Selenium |
7.20 | 17162251 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.88 | 15692506 |
MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
4.69 | 12579204 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.32 | 11000095 |
MESH:D006509 |
Hepatitis B |
|
Lamivudine |
5.08 | 17703166 |
MESH:D019694 |
Hepatitis B, Chronic |
|
Lamivudine |
5.08 | 16476009 12044531 15309715 15631357 15274664 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.88 | 16120746 12621046 15340226 |
MESH:D015658 |
HIV Infections |
|
Lamivudine |
7.02 | 20032539 11141242 17530837 9296927 |
MESH:D015658 |
HIV Infections |
|
Zidovudine |
7.02 | 20032539 11363243 11141242 17358032 11698656 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.39 | 17606976 18501091 15147373 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.86 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.05 | 15340226 16354765 18606429 16959395 8697196 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.90 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.61 | 16612254 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.80 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.44 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.47 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
4.85 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.85 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
4.20 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.26 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.32 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.52 | 15369732 16775033 15699352 |
MESH:D007674 |
Kidney Diseases |
|
Mercury |
6.52 | 17934191 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
9.92 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
9.92 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
17.67 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
17.67 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
17.67 | 18625569 |
MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
17.67 | 12579204 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.16 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
4.39 | 20370541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.15 | 16294345 17596541 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.14 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.48 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.48 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.48 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
10.64 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
10.64 | 16603448 18383874 17045692 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
10.64 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.64 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
9.76 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
9.76 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.76 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.26 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
6.58 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
6.58 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
6.58 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.58 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
6.58 | 18800350 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.78 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.44 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.04 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.77 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.55 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.75 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
9.94 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
9.94 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
9.94 | 19196722 11731420 19196723 16827153 14580682 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.55 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.40 | 16827129 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.40 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.17 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.26 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
6.26 | 15107826 |
MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
5.84 | 17358032 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.17 | 18765137 18803445 |
OMIM:124000 |
MITOCHONDRIAL COMPLEX III DEFICIENCY |
marker/mechanism |
|
| |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.48 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.61 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.78 | 17415656 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.01 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.14 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.94 | 15857846 19429709 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.00 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.85 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.84 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.84 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.51 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
2.60 | 16928823 18600527 18239605 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.00 | 19200415 19189210 19196722 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.75 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.98 | 16889571 15640375 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.86 | 17356569 18619942 15790535 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.20 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.11 | 8888407 16359493 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.25 | 15555623 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.42 | 16436463 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.41 | 16049721 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.09 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
3.12 | 16525653 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.66 | 16500647 16929163 15113037 19003803 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.67 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
2.97 | 16412576 18191903 11535288 19114014 11445065 15451049 16140633 19232380 18619942 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
4.06 | 18197244 15795934 15927086 15574749 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.25 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.16 | 17983394 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.89 | 15087411 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.16 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.54 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.44 | 11118676 11222880 11399792 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.44 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.10 | 16729912 16868541 15897917 18437689 15749863 16888761 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.10 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.10 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.10 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.30 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.54 | 11422049 12752131 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.99 | 16160472 18286688 15538739 18722050 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.21 | 17922066 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.82 | 18990726 |
MESH:D012206 |
Rhabdomyolysis |
|
Lamivudine |
5.53 | 9296927 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.16 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.97 | 15675481 17203757 15625365 17710206 18313854 16767912 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.23 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.78 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.89 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
5.89 | 14763951 1511512 11044598 3137016 16876388 11738929 17978042 15475178 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.65 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.65 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.55 | 17203757 15625365 16767912 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.56 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.56 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.03 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.76 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.54 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.75 | 17522103 16951190 16424979 18396642 15786421 17498489 18567086 19084572 17172411 19015929 |
MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
2.75 | 17696246 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.60 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.13 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.90 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.35 | 17909728 16010429 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.97 | 16280240 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.23 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.51 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.31 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.31 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
8.31 | 8653321 16712894 17572228 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.63 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.31 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
3.86 | 16803524 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.28 | 14692618 |
MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
4.74 | 12579204 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.59 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.52 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.21 | 17638931 17334414 17678736 16364871 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.25 | 15886252 |